PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32674904-9	2020	Moreover, LPC+imipenem and LPC+ceftazidime significantly decreased and increased the TNF-alpha and IL-10 levels, respectively, in comparison with the untreated controls and monotherapies.	Imipenem	14-22	tumor necrosis factor	Mus musculus	85-94	
10722633-1	2000	Staphylococcus aureus killed during imipenem or ceftazidime chemotherapy in mice elicited an early release of tumor necrosis factor alpha (TNF-alpha) into the systemic circulation.	Imipenem	36-44	tumor necrosis factor	Mus musculus	110-137	
10722633-1	2000	Staphylococcus aureus killed during imipenem or ceftazidime chemotherapy in mice elicited an early release of tumor necrosis factor alpha (TNF-alpha) into the systemic circulation.	Imipenem	36-44	tumor necrosis factor	Mus musculus	139-148	
34991848-5	2022	The therapeutic efficacy and TNF-alpha and IL-10 levels were determined in murine models of PS and pneumonia induced by Pa39 and Pa238 and treated with LPC, imipenem or ceftazidime, alone or in combination.	Imipenem	157-165	tumor necrosis factor	Mus musculus	29-38	
34991848-9	2022	Moreover, LPC+imipenem and LPC+ceftazidime significantly decreased and increased the TNF-alpha and IL-10 levels, respectively, in comparison with the untreated controls and monotherapies.	Imipenem	14-22	tumor necrosis factor	Mus musculus	85-94	
26375251-5	2015	Treatment with atorvastatin along with imipenem reduced the lung bacterial load and pro-inflammatory cytokines (IL-1beta and TNFalpha) level in BALF.	Imipenem	39-47	tumor necrosis factor	Mus musculus	125-133